Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Nylidrin hydrochloride [USP]
RN: 849-55-8
UNII: EC69E3PW7E
InChIKey: CLJHABUMMDMAFA-UHFFFAOYSA-N

Note

  • A beta-adrenergic agonist. Nylidrin causes peripheral vasodilation, a positive inotropic effect, and increased gastric volume of gastric juice. It is used in the treatment of peripheral vascular disorders and premature labor.

Molecular Formula

  • C19-H25-N-O2.Cl-H

Molecular Weight

  • 335.872
 

Classification Code

  • Drug / Therapeutic Agent
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Regulatory Agencies (Superlist Locators)

Other Resources (Internet Locators)


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Nylidrin hydrochloride
  • Nylidrin hydrochloride [USP]

Synonyms

  • 1-p-Hydroxyphenyl-2-(1'-methyl-3'-phenylpropylamino)-1-propanol hydrochloride
  • Arlibide
  • Arlidin
  • Benzenemethanol, 4-hydroxy-alpha-(1-((1-methyl-3-phenylpropyl)amino)ethyl)-, hydrochloride
  • Bufedon
  • Buphedrin
  • Buphenin hydrochloride
  • Buphenine hydrochloride
  • Dilatol
  • Dilydrin
  • EINECS 212-701-0
  • NSC 142004
  • Nylidrin HCl
  • Nylidrin hydrochloride
  • p-Hydroxy-alpha-(1-((1-methyl-3-phenylpropyl)amino)ethyl)benzyl alcohol hydrochloride
  • Penitardon
  • Rolidrin
  • Rudilin
  • Suprifen psb hydrochloride
  • Tocodilydrin
  • Tocodrin
  • UNII-EC69E3PW7E
  • Vasiten
  • Verina

Systematic Names

  • Benzenemethanol, 4-hydroxy-alpha-(1-((1-methyl-3-phenylpropyl)amino)ethyl)-, hydrochloride
  • Benzyl alcohol, p-hydroxy-alpha-(1-((1-methyl-3-phenylpropyl)amino)ethyl)-, hydrochloride
  • Buphenine hydrochloride

Registry Numbers

CAS Registry Number

  • 849-55-8

FDA UNII

  • EC69E3PW7E

Other Registry Numbers

  • 3595-06-0
  • 900-01-6
  • 91408-84-3

Related Registry Number

  • 447-41-6 (Parent)

System Generated Number

  • 0000849558

Molecular Formulas

Molecular Formula

  • C19-H25-N-O2.Cl-H

Molecular Formula Fragments

  • C19-H25-N-O2
  • Cl-H
  • COMPONENT

Structure Descriptors

InChI

1S/C19H25NO2.ClH/c1-14(8-9-16-6-4-3-5-7-16)20-15(2)19(22)17-10-12-18(21)13-11-17;/h3-7,10-15,19-22H,8-9H2,1-2H3;1H

InChIKey

CLJHABUMMDMAFA-UHFFFAOYSA-N

Smiles

c1([C@@H]([C@@H]([NH2+][C@@H](CCc2ccccc2)C)C)O)ccc(O)cc1.[ClH-]

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intraperitoneal 136mg/kg (136mg/kg)   Yakkyoku. Pharmacy. Vol. 24, Pg. 431, 1973.
mouse LD50 intravenous 40mg/kg (40mg/kg)   "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972Vol. -, Pg. 351, 1972.
mouse LD50 oral 250mg/kg (250mg/kg)   "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972Vol. -, Pg. 351, 1972.
rat LD50 intraperitoneal 380mg/kg (380mg/kg)   "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972Vol. -, Pg. 351, 1972.
rat LD50 intravenous 37400ug/kg (37.4mg/kg)   United States Patent Document. Vol. #3542870,
rat LD50 oral > 4800mg/kg (4800mg/kg)   Drugs in Japan Vol. 6, Pg. 538, 1982.